Optimization of small-molecule probes or drugs is a lengthy, challenging and resource-intensive process. Lack of automation and reliance on skilled medicinal chemists is cumbersome in both academic and industrial settings. Here, we demonstrate a high-throughput hit-to-lead process based on the biocompatible SuFEx click chemistry. A modest high-throughput screening hit against a bacterial cysteine protease SpeB was modified with a SuFExable iminosulfur oxydifluoride [RN=S(O)F2] motif, rapidly diversified into 460 analogs in overnight reactions, and the products directly screened to yield drug-like inhibitors with 300-fold higher potency. We showed that the improved molecule is drug-like and biologically active in a bacteria-host coculture. Since these reactions can be performed on a picomole scale to conserve reagents, we anticipate our methodology can accelerate the development of robust biological probes and drug candidates. The introduction of high-throughput screening (HTS) robotics, liquid handler systems, and assay miniaturization have revolutionized screening of bioactive molecules. Relatively inexpensive HTS processes are now routinely used in cell-based and in vitro assays against biomedically relevant targets. Nevertheless, compound optimization is typically necessary to improve target specificity, potency, and stability. Lead optimization relies heavily on medicinal chemists, and extensive time and labor costs remain significant hurdles for probe and drug development. Click chemistry has found broad applications in materials chemistry, chemical biology, and drug development since the concept was first introduced in 1999 1-2. The sulfur(VI) fluoride exchange (SuFEx) represents the most recent set of ideal click chemistry transformations 3. Specifically, aryl fluorosulfates (ArOSO2F) and iminosulfur oxydifluorides (RN=S(O)F2) are readily synthesized using two connective oxyfluoride gases, sulfuryl fluoride (SO2F2) and thionyl tetrafluoride (O=SF4), respectively 4. These two S VI −F motifs have been successfully used as connective linkers in polymer synthesis and for construction of various functional molecules 5-7. Sulfonyl fluoride (RSO2F) and aryl fluorosulfate moieties have been successfully introduced into bioactive molecules in chemical biology and drug discovery 8-11 , especially as covalently binding warheads 12. However, the potential of SuFEx to unite diverse modules using an O=SF4 hub has not been explored in medicinal chemistry. While the copper(I)catalyzed azide-alkyne cycloaddition (CuAAC) reaction has been used in proof-of-concept studies on lead Statistical analysis was performed using one-way ANOVA with Dunnett's multiple comparisons test, *≤ 0.05. Supporting Information Additional texts, figures, and tables are provided. AUTHOR INFORMATION # Authors contributed equally.